JP2014111672A5 - - Google Patents

Download PDF

Info

Publication number
JP2014111672A5
JP2014111672A5 JP2014056829A JP2014056829A JP2014111672A5 JP 2014111672 A5 JP2014111672 A5 JP 2014111672A5 JP 2014056829 A JP2014056829 A JP 2014056829A JP 2014056829 A JP2014056829 A JP 2014056829A JP 2014111672 A5 JP2014111672 A5 JP 2014111672A5
Authority
JP
Japan
Prior art keywords
derivatives
pharmaceutical composition
alcohol
pyrrolidone
poe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014056829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014111672A (ja
JP6215102B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014056829A priority Critical patent/JP6215102B2/ja
Priority claimed from JP2014056829A external-priority patent/JP6215102B2/ja
Publication of JP2014111672A publication Critical patent/JP2014111672A/ja
Publication of JP2014111672A5 publication Critical patent/JP2014111672A5/ja
Application granted granted Critical
Publication of JP6215102B2 publication Critical patent/JP6215102B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014056829A 2012-09-14 2014-03-19 医薬組成物 Expired - Fee Related JP6215102B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014056829A JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012203293 2012-09-14
JP2012203293 2012-09-14
JP2014056829A JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013176862A Division JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Publications (3)

Publication Number Publication Date
JP2014111672A JP2014111672A (ja) 2014-06-19
JP2014111672A5 true JP2014111672A5 (https=) 2016-09-23
JP6215102B2 JP6215102B2 (ja) 2017-10-18

Family

ID=49226452

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013176862A Expired - Fee Related JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物
JP2014056829A Expired - Fee Related JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013176862A Expired - Fee Related JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Country Status (7)

Country Link
US (1) US20150238606A1 (https=)
EP (1) EP2895164A1 (https=)
JP (2) JP5686874B2 (https=)
CN (1) CN104619320A (https=)
IN (1) IN2015DN02377A (https=)
RU (1) RU2621615C2 (https=)
WO (1) WO2014042043A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP5460797B1 (ja) * 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6503627B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬液体組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6242655B2 (ja) * 2013-10-29 2017-12-06 リンテック株式会社 機能性物質の放出方法、機能性物質の放出用キット及び放出性組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
MX2018014485A (es) * 2016-05-25 2019-08-12 Glenmark Pharmaceuticals Ltd Composiciones topicas estables de luliconazol.
CN107865825B (zh) * 2016-09-28 2022-05-20 四川海思科制药有限公司 一种卢立康唑外用喷雾剂药物组合物及其制备方法
CN108934161A (zh) * 2017-03-29 2018-12-04 日本农药株式会社 用于治疗感染症的医药组合物
JP6582158B1 (ja) * 2017-10-30 2019-09-25 科研製薬株式会社 爪白癬治療用の外用製剤
CN108143711A (zh) * 2018-01-13 2018-06-12 天津双硕医药科技有限公司 一种含有卢立康唑的外用乳膏组合物
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
CN113774390B (zh) * 2021-08-12 2023-08-04 上海新阳半导体材料股份有限公司 一种用于化学机械抛光后的清洗液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101373955B1 (ko) 2006-03-08 2014-03-12 니혼노야쿠가부시키가이샤 외용의 의약 조성물
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
HUE029707T2 (en) * 2007-08-27 2017-03-28 Nihon Nohyaku Co Ltd Anti-fungal dermatitis
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
US20090130232A1 (en) * 2007-11-20 2009-05-21 Mohammed Zahra Composition and method for treatment of oral inflammation an ulceration
US8445717B2 (en) * 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
EP2745692A1 (en) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
KR101409792B1 (ko) * 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
US10130610B2 (en) * 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) * 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) * 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP6291256B2 (ja) * 2011-02-17 2018-03-14 シーエイチディー・バイオサイエンス，インコーポレーテッド ペルオキシα−ケトカルボン酸を含む組成物、および該組成物を産生し、そして用いるための方法

Similar Documents

Publication Publication Date Title
JP2014111672A5 (https=)
JP2014074012A5 (https=)
RU2015108930A (ru) Фармацевтическая композиция, содержащая луликоназол
JP2014509655A5 (https=)
HRP20210183T1 (hr) 18f-obilježeni inhibitori specifičnog membranskog antigena prostate (psma) i njihova uporaba kao sredstava za vizualizaciju raka prostate
HRP20201043T1 (hr) Spojevi 4-amino-imidazokinolina
JP2012523410A5 (https=)
MX2017009489A (es) Composicion auto-emulsionante de acido graso ?3.
JP2014129360A5 (https=)
MX2016000307A (es) Farmaco para el tratamiento de la esteatosis hepatica no alcoholica.
MX377728B (es) Composición que comprende un compuesto lípido, un triglicerido y un tensioactivo, y métodos de uso de la misma.
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
RU2015136849A (ru) Композиции, содержащие 15-он эпк, и способы их применения
EP4454708A3 (en) A tablet comprising a methoxyurea derivative and mannitol particles
JP2014218522A5 (https=)
SG10201809228RA (en) Lyophilized formulation of hgf
RU2020123899A (ru) Новые соединения, ингибирующие mtor
JP2013525485A5 (https=)
RU2016137349A (ru) Успокоительный феромон для кошек
PE20160037A1 (es) Formulacion farmaceutica que comprende fosfatidilcolina para el tratamiento de colitus ulcerosa
JP2017505336A5 (https=)
JP2016538288A5 (https=)
JP2016079180A5 (https=)
JP2014508170A5 (https=)
JP2016531886A5 (https=)